CellaVision's Annual General Meeting in 2020 will take place in Lund at three o´clock CET on June 16, 2020
The superior body of the company is the Annual General Meeting, where the shareholders influence in the company is exercised. At the Annual General Meeting decisions are made on a number of central items of business, including the appropriation of the company’s profits, adoption of the income statement and balance sheet, discharge from liability of the Board of Directors and President/CEO, election of the Board of Directors and auditor and fees to the Board of Directors and auditor.
The shareholders of CellaVision AB (publ) reg. no. 556500-0998 (the “Company”) are hereby summoned to attend the Annual General Meeting (“AGM”) on 16 June 2020 at 15.00 CEST at the Company’s premises, at Mobilvägen 12, in Lund, Sweden. Registration starts at 14.30 CEST and will stop when the meeting starts.
Due to the spread of the coronavirus (COVID-19), CellaVision is taking precautionary measures in relation to the Annual General Meeting on June 16, 2020.
CellaVision is mindful of the health and well-being of its shareholders and employees and considers it important to reduce the risk of transmission of the virus. According to the Public Health Agency of Sweden, there is now a community spread of the coronavirus in Sweden, and persons over the age of 70 and persons who do not feel well are urged to stay at home.
Given the current circumstances, and with the aim to keep the number of attendees to a minimum, CellaVision encourages shareholders not to attend in person and instead use the option to appoint a proxy holder who can vote on their behalf. Shareholders who choose to authorize a proxy holder can find the relevant document below “Proxy”.
The Act (2020:198) on temporary exceptions to facilitate the execution of general meetings in companies and other associations give companies, among other things, the right to collect proxies with a designated representative to reduce the number of physically present at the Annual General Meeting. If you choose to not attend in person and do not want to appoint your own proxy holder, there is the possibility to vote via CellaVision’s designated representative. Shareholders who choose to authorize the company's designated representative can find the relevant document below “Power of Attorney”.
In order to minimize the potential risk of transmission of the virus, CellaVision will ensure that the meeting is as short and concise as possible. The planned presentations will be kept to a minimum, external guests will not attend the meeting, and participation by both Board members and the Company’s Executive Management team will be minimized. To further minimize the length of the Annual General Meeting, no refreshments or products will be offered in connection with the meeting.
CellaVision closely monitors the development of events and will, if necessary, update the above described precautionary measures prior to the Annual General Meeting. For up-to-date general information about the coronavirus, please read more at the Public Health Agency of Sweden’s website.
Shareholders wishing to have matters considered at the Annual General Meeting can send a written request by email to firstname.lastname@example.org or ordinary mail to: The Board of Directors, CellaVision AB, Mobilvägen 12, SE 223 62 Lund. The request must have been received at the latest seven weeks before the Annual General Meeting in order to be included in the notice to attend and thus the agenda of the Annual General Meeting.